CHICAGO (TVT2019 – Structural Heart Summit), June 13, 2019 – Materialise, a global 3D printing software and solutions company, has received FDA clearance for its Mimics Enlight cardiovascular planning software suite. The first release will support clinicians planning complex transcatheter mitral valve replacement (TMVR) procedures.
Read more
Detroit (USA) - May 20. Materialise NV (Nasdaq: MTLS), a global leader in 3D printing solutions, has partnered with HP, Nikon and Essentium to bring improved productivity and connectivity to additive manufacturing operations. The partnerships, announced during the 2019 RAPID+TCT Conference in Detroit, will support the adoption of 3D printing by industrial manufacturers. Materialise also announced that it will release a new version of its 3D printing operations management software, Streamics 8 in June 2019.
Read more
DETROIT – May 20 – Today at the RAPID+TCT Conference, Materialise and HP Inc. announced an expansion of innovative work to pave the way towards industrial-scale 3D printing, including integration of Materialise’s industry-leading software with HP’s breakthrough Jet Fusion 3D printing solutions, and an important certification validating the HP Jet Fusion 580/380 solutions as fully compatible with Materialise Mimics in Print software for use in healthcare.
Read more
Executive Chairman Peter Leys commented, “In the year’s opening quarter, all three of our segments performed well. Materialise Software and Materialise Medical, which continue to invest in both sales and marketing and research and development, combined healthy double-digit revenue growth rates with solid double-digit EBITDA margins. In spite of the continuing macro-economic uncertainties, in particular in the automotive sector, Materialise Manufacturing also realized growth, both in terms of revenue and, more significantly, in terms of EBITDA. We believe we are on track to meet our financial guidance for 2019.”
Read more
Fluidda announces a new phase in its collaboration with Materialise, to expand personalized treatment options in the respiratory care, building on its image based software. As part of the partnership, Materialise invests €2.5 million in Fluidda and Wilfried Vancraen, founder and CEO of Materialise, will join the board of directors at Fluidda.
Read more
